Loading...
XSHG600319
Market cap259mUSD
Dec 25, Last price  
4.79CNY
1D
0.20%
1Q
27.68%
Name

Weifang Yaxing Chemical Co Ltd

Chart & Performance

D1W1MN
XSHG:600319 chart
P/E
291.80
P/S
2.25
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
0.48%
Rev. gr., 5y
-16.32%
Revenues
825m
-2.58%
990,084,8661,211,780,9871,635,541,3081,944,694,6232,081,403,8021,721,626,2872,097,844,0832,111,631,0011,713,399,2031,628,244,0051,489,024,4281,311,503,4071,457,437,5781,949,780,6742,010,163,7721,655,120,19649,293,774192,701,715846,653,311824,850,305
Net income
6m
-94.15%
39,688,83937,284,10732,286,23520,115,33615,684,27607,210,072008,793,0230026,781,67426,614,6273,107,47600193,025,919108,844,0586,364,457
CFO
-168m
L
145,625,090158,436,550185,518,582136,752,93598,040,470276,593,507272,623,753182,835,15645,853,926081,800,90329,391,42350,950,25485,424,043151,397,984188,004,66400123,025,330-167,751,563
Dividend
Jun 15, 20090.02 CNY/sh
Earnings
Apr 29, 2025

Profile

Weifang Yaxing Chemical Co., Ltd. engages in the research and development, production, operation, import, and sale of chemical materials in China and internationally. It offers chlorinated polyethylene CPE, azodicarbonamide foaming agent, industrial hydrazine hydrate, sodium hydroxide, liquid chlorine, and hydrochloric acid. The company was founded in 1994 and is headquartered in Weifang, China.
IPO date
Mar 26, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
824,850
-2.58%
846,653
339.36%
192,702
290.93%
Cost of revenue
841,012
748,393
204,064
Unusual Expense (Income)
NOPBT
(16,162)
98,261
(11,363)
NOPBT Margin
11.61%
Operating Taxes
406
10,265
23
Tax Rate
10.45%
NOPAT
(16,568)
87,995
(11,386)
Net income
6,364
-94.15%
108,844
-43.61%
193,026
 
Dividends
Dividend yield
Proceeds from repurchase of equity
298,200
BB yield
-15.41%
Debt
Debt current
748,457
511,880
704,595
Long-term debt
490,251
58,562
26,802
Deferred revenue
54,107
55,289
56,471
Other long-term liabilities
13,919
169,051
24,200
Net debt
1,198,129
493,936
644,306
Cash flow
Cash from operating activities
(167,752)
123,025
CAPEX
(248,529)
Cash from investing activities
(247,694)
31,988
Cash from financing activities
385,370
187,871
FCF
(48,339)
(337,364)
(254,685)
Balance
Cash
40,506
76,507
86,980
Long term investments
73
1
110
Excess cash
34,174
77,455
Stockholders' equity
(431,067)
607,043
534,876
Invested Capital
1,967,592
1,341,059
961,452
ROIC
7.64%
ROCE
7.15%
EV
Common stock shares outstanding
318,223
351,110
315,594
Price
5.78
4.90%
5.51
-0.72%
5.55
6.94%
Market cap
1,839,328
-4.93%
1,934,615
10.45%
1,751,547
6.94%
EV
3,040,869
2,428,551
2,395,853
EBITDA
48,027
150,646
10,303
EV/EBITDA
63.32
16.12
232.54
Interest
51,439
46,793
69,938
Interest/NOPBT
47.62%